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Abstract
Maternal dietary protein restriction during pregnancy is associated with low fetal birth weight and leads to renal morphological 
and physiological changes. Different mechanisms can contribute to this phenotype: exposure to fetal glucocorticoid, altera-
tions in the components of the renin-angiotensin system, apoptosis, and DNA methylation. A low-protein diet during gestation 
decreases the activity of placental 11ß-hydroxysteroid dehydrogenase, exposing the fetus to glucocorticoids and resetting the 
hypothalamic-pituitary-adrenal axis in the offspring. The abnormal function/expression of type 1 (AT1R) or type 2 (AT2R) AngII 
receptors during any period of life may be the consequence or cause of renal adaptation. AT1R is up-regulated, compared with 
control, on the first day after birth of offspring born to low-protein diet mothers, but this protein appears to be down-regulated 
by 12 days of age and thereafter. In these offspring, AT2R expression differs from control at 1 day of age, but is also down-
regulated thereafter, with low nephron numbers at all ages: from the fetal period, at the end of nephron formation, and during 
adulthood. However, during adulthood, the glomerular filtration rate is not altered, due to glomerulus and podocyte hypertrophy. 
Kidney tubule transporters are regulated by physiological mechanisms; Na+/K+-ATPase is inhibited by AngII and, in this model, 
the down-regulated AngII receptors fail to inhibit Na+/K+-ATPase, leading to increased Na+ reabsorption, contributing to the 
hypertensive status. We also considered the modulation of pro-apoptotic and anti-apoptotic factors during nephrogenesis, since 
organogenesis depends upon a tight balance between proliferation, differentiation and cell death.
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The role of the kidney in the pathogenesis of hyperten-
sion has long been established, although recent studies 
challenge renal hegemony and suggest an important role 
for vascular cells as well (1,2). In recent years, this view 
has expanded and now includes the concept that chronic 
hypertension and kidney dysfunction are also related to 
events that occur during the prenatal period. This relation-
ship between fetal programming of disease and the kidney 
suggests that several mechanisms can predispose to hyper-
tension during adulthood through impaired nephrogenesis. A 
recent overview considered the role of fetal programming in 
the development of adult kidney disease and hypertension 
(3). The purpose of the present review is to describe some 
of the mechanisms that can affect the kidney, with special 
focus on the renin-angiotensin system (RAS). The kidney 
is an organ that is centrally related to the development of 
hypertension through its function of renal sodium handling 
and intravascular fluid volume homeostasis. Importantly, 
following cross transplants, if the donor is hypertensive, the 
recipient becomes hypertensive too, since factors intrinsic 
to the kidney itself affect blood pressure (4,5). In 1968, 
Zeman (6) first reported that rat offspring of mothers that 
were severely protein-restricted (6% casein-diet) through-
out pregnancy had kidneys that contained fewer glomeruli 
than offspring of mothers on a normal diet (24% casein). 
Nephrogenesis requires a fine balance of many factors that 
can be disturbed by intrauterine growth restriction (IUGR), 
leading to a low nephron endowment (7).
The aim of this review is also to present further evidence 
supporting an association between maternal low-protein 
ingestion and the increased prevalence of hypertension, 
as well as progression towards kidney dysfunction in adult 
life. Various potential mechanisms for this association are 
discussed, specifically the low nephron number hypothesis 
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and related cellular and molecular mechanisms that have 
been proposed. Some factors involved in nephrogenesis, 
such as glucocorticoid exposure, regulation of components 
of the RAS, apoptosis, and p53 gene methylation, have been 
investigated in different low birth weight (LBW) models and 
will be considered in this review.
Maternal-fetal environment and adult disease
The size that the fetus can attain depends on the ma-
ternal-fetal nutrient supply and the space that the maternal 
environment can provide (8). Low maternal socioeconomic 
level and poor maternal nutritional status will reduce the 
nutrient supply to the developing fetus. Similarly, factors 
that frustrate the passage of nutrients through the placenta, 
such as smoking and hypertension, are associated with 
an increased risk for the development of the fetal origins 
of adult diseases. Nearly two decades ago, Barker (9) 
presented the theory that the maternal environment could 
induce adult diseases, based on observed epidemiologic 
associations between LBW and increased risk for ischemic 
heart disease, type 2 diabetes, and hypertension (10). The 
first associations found were between LBW and later life hy-
pertension and cardiovascular disease (10-12). High blood 
pressure occurs at a higher incidence in children and adults 
who were of LBW (12). A systematic review of 80 studies 
that described the relationship of blood pressure with birth 
weight reported that systolic BP is lower by approximately 
2 mmHg for every 1-kg increase in birth weight (13). Among 
Pima Indians, patients who had diabetes and a history of 
maternal undernutrition also displayed an increased risk to 
develop diabetic nephropathy (14). Moreover, poor maternal 
nutrition is associated with more rapid progression of other 
kidney diseases, such as IgA nephropathy, membranous 
nephropathy, and minimal-change disease, suggesting that 
the kidneys of these infants are more vulnerable to future 
insults (15). Nevertheless, the strength of the association 
between the maternal-fetal environment and subsequent 
hypertension remains widely debated. Moreover, some 
investigators claim that the suggested association is the 
result of inappropriate adjustments for confounding factors 
(16). For example, Huxley et al. (13) found a trend towards 
a weaker association between LBW and hypertension 
in larger compared with smaller studies (16). However, 
it seems that, although the relation is not invariant, the 
bulk of evidence suggests an important direct or indirect 
interaction between birth weight and subsequent hyperten-
sion (17). These observations have led to the formulation 
of an important conceptual construct that pertains to the 
fetal origins of adult disease. This theory states that, dur-
ing development, body organs pass through a period of 
plasticity and sensitivity to the environment, which leaves 
a durable imprint that affects subsequent health. Subop-
timal intrauterine conditions may result in impaired fetal 
growth and the production of phenotypes that are better 
matched to the inadequate intrauterine environment. These 
adaptive processes are aimed to increase the likelihood 
of survival in utero and after birth, with expected continua-
tion of borderline or inadequate environmental conditions. 
However, this response may result in adverse long-term 
consequences later in life, especially when the postnatal 
environment affords more favorable growth conditions than 
those experienced in utero. One of the most studied aspects 
with regard to Barker’s theory (9) has been the fetal origin 
of adult diabetes. Numerous reports have demonstrated 
an association between poor maternal nutritional status 
and subsequent development of pancreatic endocrine 
insufficiency and diabetes in experimental animals and 
humans (18,19). However, a detailed consideration of the 
relationship between maternal low protein ingestion and 
diabetes is beyond the scope of this review.
Experimental studies have been conducted using differ-
ent models of IUGR. Among others, maternal low-protein 
diet (20), 50% food restriction (21) and glucocorticoid expo-
sure (22) are the focus of many studies because they reflect 
the situation of people who live in poverty. Both of them 
result in LBW leading the fetus to develop adult diseases, 
like diabetes, heart disease and hypertension. 
Glucocorticoid exposure in utero
In 1993, Benediktsson et al. (22) showed that rats 
exposed to excess glucocorticoid in utero developed 
adult hypertension. Since that study, the early exposure 
of the fetus to glucocorticoids has been used as a model 
of fetal programming in different species (23-25). Fetal 
protection from maternal glucocorticoid is normally affected 
by placental 11ß-hydroxysteroid dehydrogenate type 2 
(11ß-HSD2), which converts cortisol and corticosterone to 
inactive products (cortisone, 11-dehydrocorticosterone). 
The activity of 11ß-HSD2 correlates positively with birth 
weight and negatively with placental weight in rats (22), 
suggesting an important role for this enzyme in regulating 
fetal growth and development.
Glucocorticoids are widely used in the management of 
women at risk of preterm delivery to accelerate pulmonary 
maturation. Antenatal glucocorticoids are associated with 
a reduction in birth weight in human studies (26). Preterm 
children treated postnatally with glucocorticoid display 
elevated blood pressure at an early age (27). Dexametha-
sone (DEX) is a synthetic glucocorticoid non-metabolized 
by 11ß-HSD2 that readily crosses the placental barrier and 
has been used to study the effects of fetal glucocorticoid 
exposure. Another model that mimics the effects of a ma-
ternal low-protein diet is the treatment during pregnancy 
with carbenoxolone, an 11ß-HSD2 inhibitor (28).
Feeding a low-protein diet to pregnant rat dams reduces 
the activity of placental 11ß-HSD2 by 33%, programming hy-
pertension in the adult offspring (29). A major consequence 
of maternal protein restriction appears to be a resetting of the 
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hypothalamic-pituitary-adrenal axis function in the offspring 
(24). Gestational low-protein-exposed rats exhibit increased 
sensitivity to low-normal concentrations of corticosterone 
and have increased numbers of glucocorticoid receptors in 
the adrenals. In an elegant study with adrenalectomized rats, 
Gardner et al. (30) demonstrated that, in a model of maternal 
low-protein diet, adrenalectomy reduces high blood pres-
sure when compared with control animals. Corticosteroid 
replacement restores the high blood pressure in these rats, 
an indication of a glucocorticoid-dependent phenomenon 
(30). When cortisol was administered to pregnant sheep, 
the offspring showed similar changes in the expression of 
type 1 angiotensin II receptor (AT1R) compared to controls, 
suggesting that alterations in the renal RAS may be a 
mechanism by which early prenatal glucocorticoid exposure 
causes fetal programming (31).
The hypertension programmed by glucocorticoid ex-
posure is linked to pathological changes in kidneys, such 
as increased sodium transport, alterations in the RAS and 
low nephron number. Studies with DEX have revealed that 
the severity of these phenotypes depends on the timing 
and duration of glucocorticoid exposure (32). The critical 
“window” of development during which kidneys are more 
susceptible to DEX exposure is the very early stage of renal 
development, where the ureteric bud invades the meta-
nephric mesenchyme and begins to branch (33). Singh et 
al. (32) demonstrated that rat metanephric DEX exposure in 
vitro for 2 days during early nephrogenesis inhibits ureteric 
branching morphogenesis and nephrogenesis, suggesting 
that a reduction in ureteric branching morphogenesis may 
be a key mechanism through which DEX reduces nephron 
endowment.
Another study has shown that prenatal DEX is associ-
ated with an increase in Na+/H+ exchange activity in proximal 
tubules, as well as in the brush-border membrane NHE3 
protein (34). Furthermore, a recent study demonstrated that, 
in offspring exposed in utero to DEX, renal denervation at 
6 weeks of age resulted in a decrease in NHE3, NKCC2 
and NCC protein abundance to levels observed in vehicle-
treated sham rats (35).
Renin-angiotensin system
The role of the RAS in the control of blood pressure 
and homeostasis balance is well recognized. The RAS was 
accepted to have a role in kidney development, with a role 
in vasculogenesis, branching morphogenesis and develop-
ment of hypertension in the adult, as the result of a reduction 
in nephron number during nephrogenesis (7,36). 
All the components of the RAS are expressed in the em-
bryonic kidney and, in rats, the expression can be detected 
from 12 to 17 days of gestation, being higher in fetuses and 
newborn rats than in adult rats (36). Pharmacological or 
genetic alterations in the RAS during kidney development 
induce gross abnormalities, such as a hypoplastic papilla. 
Treatment of rats during active nephrogenesis with an AT1 
antagonist or with an angiotensin-converting enzyme (ACE) 
inhibitor leads to decreased nephron number (37), delayed 
nephron maturation and altered renal water handling (38). 
Human kidneys of fetuses from mothers that received an 
AT1 antagonist during gestation show poorly developed 
tubules, a reduced number of proximal tubules, poorly 
developed vasa recta and a hyperplastic juxtaglomerular 
apparatus (39).
Many studies have shown that perturbed maternal 
nutritional status alters renal renin protein and mRNA lev-
els, as well as renal angiotensin II (AngII) concentration 
(40) and changes renal expression of AngII receptors and 
mitogen-activated protein kinase (MAPK) in the pups (41), 
resulting in higher blood pressure and structural changes in 
the kidney of adult offspring. Conflicting results regarding 
RAS among the groups are explained by different levels 
of protein in the diet, different periods of treatment during 
gestation, different rat strain and, mainly, by the different 
methods adopted, such as whole kidney Western blot, 
cortex Western blot, or whole kidney RT-PCR.
Specific studies with maternal protein restriction during 
gestation have shown different modulations of RAS com-
ponents. Sahajpal and Ashton (42) showed that offspring 
of mothers that received a low-protein diet during the entire 
gestational period presented, at 4 weeks of age, fewer 
glomeruli per g kidney weight and the AT1R protein level 
was 24% greater in low-protein pups when compared with 
normally nourished pups. In another study, the same group 
showed that AT1R and AT2R was greater in the cortex (62 
and 35%, respectively) in low-protein pups at 4 weeks of 
age and renal renin activity and tissue AngII concentra-
tions were not lower in these animals (43). Vehaskari et 
al. (44) compared the levels of RAS protein and mRNA at 
1 day and 28 days of age and found that, at 1 day, AT1R 
and AT2R proteins were decreased, but that AT2R mRNA 
was increased. The same variation found by Sahajpal and 
Ashton (42) was verified at 28 days, when AT1R and AT2R 
proteins were increased, but AT1Rb and AT2R mRNA did 
not differ, suggesting that the ontogeny of the intrarenal 
RAS is altered throughout the perinatal and early postnatal 
period (44). 
Our group recently found that AT2R protein is down- 
regulated in kidneys of 16-week-old rats born to females 
that received a low-protein diet (9%) throughout gestation. 
These animals presented a total absence of AT2R in the 
glomeruli and this receptor was localized preferentially as-
sociated with intercalated cells of the distal and collecting 
segments. AT1R and its JAK-2/SOCS3 pathway proteins 
are also down-regulated in these experimental animals, as 
shown by Western blot and immunohistochemistry (20). It 
is important to note that Sahajpal and Ashton (42) and Ve-
haskari et al. (44) used 4-week-old rats, whereas we used 
adult male rats. At 4 weeks of age, rats are normotensive, 
but become progressively more hypertensive at 6 to 8 weeks 
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of age (42-44). For this reason, the cited groups studied 
the role of RAS in the pathogenesis of hypertension and 
our group focused on the effects of hypertension on renal 
RAS, obtaining opposite results for AT1R.
We also found that podocytes appear to be larger and 
crushed in low-protein rats (Figure 1), suggesting that 
changes in renal functions favor excess hydroelectrolyte 
re-absorption by the kidney, and as such might potentiate the 
programming of adult hypertension. These morphological 
changes could be attributed to an adaptation to the reduced 
nephron number and, consequently, to glomerular hyper-
filtration and overflow in low-protein offspring, and could 
account for the breakdown in optimal glomerular filtration 
barrier function. To confirm this hypothesis, ultrastructural 
analysis by electron microscopy is necessary.
In another study, whole kidneys from 12-day-old 
animals were prepared for Western blot and revealed 
that AT1R and AT2R are down-regulated in gestational 
low-protein-exposed animals (Figure 2) and that the same 
offspring present a low nephron number when compared 
with offspring of mothers that received normal diets during 
gestation (Table 1). Data demonstrating fewer glomeruli 
in these animals confirm reports from other groups that 
have obtained similar findings in different age groups and 
models (45,46).
Figure 3 presents an overview of our results regarding 
kidney offspring status during the fetal period, postnatal and 
adult life after maternal protein restriction during gestation, 
taking into account the RAS, nephron number and renal 
function. This Figure depicts results from different experi-
ments, in which dams were fed a 6% casein diet and were 
compared with dams fed a 17% casein diet (normoproteic). It 
may be observed that, in spite of a reduced nephron number 
from the fetal period onwards, the adult low-protein offspring 
presented a similar glomerular filtration rate (GFR) to that 
observed in normal-protein rats, which may be explained by 
the larger filtration area and larger glomerular tuft volume 
in parallel to podocyte hypertrophy. Another factor that can 
contribute to the similar GFR is that AT2R is down-regulated 
in the efferent arteriole, which leads to vasoconstriction, 
thus increasing the interglomerular pressure.
Other groups obtained similar GFR results when they 
studied young rats (42,47), but when renal function was 
analyzed during old age, low-protein rats presented a sig-
nificant decrease in GFR, which means that the age-related 
decline in GFR was manifested earlier in low-protein rats 
than in controls (47).
The hypothesis that the fetal kidney is programmed to 
inappropriately retain Na+ in later life has been corroborated 
by different studies (48,49). Alwasel and Ashton (50), in a 
study of renal function and Na+ transporters in 4-week-old 
male rats born to low-protein diet dams, found that GFR 
was unchanged, suggesting that single nephron GFR may 
be increased. In addition, these investigators reported that 
Na+ transporter protein was unchanged, while the Na+/K+-
ATPase-α1 subunit was absent in the kidney of low-protein 
rats. Interestingly, in a Western blot study, we found that, 
at the end of nephrogenesis, the ß1 subunit of the Na+/K+-
ATPase protein was also down-regulated in male low-protein 
rats, but that at 16 weeks of age the protein was increased 
in these animals when compared with the normal group 
(Figure 4). This result corroborates the suggestion of do 
Carmo Pinho et al. (47) that the transcriptional up-regulation 
of Na+ transport could give origin to hypertension in this 
Figure 1. Effects of maternal protein restriction on podocyte morphology. A, Glomeruli from a rat born to a dam fed a 
normal-protein diet. B, Glomeruli from a rat born to a dam fed a low-protein (LP) diet. Immunoperoxidase assay was 
performed against AT1R antibody (brown - arrow). The arrowheads show podocytes in A and B but that appears to be 
enlarged in the kidney of an LP rat (B). 
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model. AngII AT2R is an effective inhibitor of Na+/
K+-ATPase (51) and it is possible that the down-
regulated RAS found in 16-week-old low-protein 
males (20) might lead to a lack of inhibition of Na+/
K+-ATPase, explaining results obtained by Western 
blotting, and the low sodium excretion rate, since 
Na+/K+-ATPase participates in Na+ reabsorption in 
the basolateral membrane (Figure 4). However, it is 
also possible that the high Na+/K+-ATPase expres-
sion does not indicate that all the excess protein is 
on the basolateral surface. Fekete et al. (52) dem-
onstrated that AngII promotes Na+/K+-ATPase-α1 
subunit translocation from the cytoskeletal fraction 
into the cytosol under experimental circumstances 
and we must take this into account.
Previous experiments demonstrated the involve-
ment of AngII in the regulation of Na+ transporters; 
however, the influence of fetal programming on the 
physiological function of these transporters is still 
unclear. Dagan et al. (34) demonstrated that fetal pro-
gramming by DEX in rats increases proximal tubule 
transport in part by stimulating Na+/H+ exchanger 
activity and Tiwari et al. (53) recently showed that 
gender and age result in differential regulation of NaCl 
antiporter and ENaC in AngII-infused mice.
The RAS balance is disrupted in kidneys from 
offspring of low-protein-fed mothers during different 
ages, and AngII receptors are expressed in all seg-
ments of the nephron, contributing to the increased 
sodium re-absorption in proximal tubules and to the 
final sodium excretion rate (20). 
Figure 2. Effects of maternal protein restriction on expression of kidney 
renin-angiotensin system-associated proteins, at 12 days of age. The fig-
ure shows the results obtained in whole-tissue extracts that were immu-
noblotted for AT1R and AT2R, as a percentage of protein content, in the 
NP and LP kidneys. Scanning densitometry results are reported relative 
to NP, with a value of 100% being assigned to the NP rats. Columns and 
bars represent the mean ± SEM. AT1R and AT2R = type 1 and type 2 
angiotensin II receptors; NP = normal protein; LP = low protein. *P < 0.05, 
NP vs LP (Student t-test).
Figure 3. Schematic figure showing an overview of the interaction of the renin-angiotensin system (RAS) and the kidney from the fetal 
period to adult life. Ages are specified on the line. AT1R = type 1 angiotensin II receptor; AT2R = type 2 angiotensin II receptor; GFR 
= glomerular filtration rate; LP = low protein; NP = normal protein. 
Table 1. Weight, number of glomeruli, cortical volume, and mean glom-
erular volume, at 12 days of age of rat pup kidneys born to mothers fed 
a 17% protein diet (normal diet, NP) and a 6% protein diet (low-protein 
diet, LP).
 Rat weight 
(g)
No. of 
glomeruli
Absolute cortical 
volume (mm3)
Mean glomerular 
volume (µm3)
NP 26.96 ± 0.78 9382 ± 1171* 256.29 ± 63.7 160.70 ± 16.7*
LP 25.80 ± 0.88 4980 ± 880 314.56 ± 26.07 414.71 ± 35
Data are reported as means ± SEM. *P ≤ 0.05 vs LP (Student t-test).
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Our low urinary sodium excretion data may also 
be explained by previous findings showing that 
excess fetal glucocorticoid, such as observed in 
maternal undernutrition status programs, reduced 
the expression of placental, central nervous sys-
tem and renal 11ß-HSD2 (see section above). As 
discussed above, the renal 11ß-HSD2 normally 
serves to prevent illicit access of glucocorticoids 
to the renal mineralocorticoid receptors, thereby 
maintaining mineralocorticoid receptors specific-
ity for aldosterone, and, accordingly, humans with 
11ß-HSD2 deficiency exhibit hypertension (54). A 
programmed reduction in renal 11ß-HSD2 would 
be expected to increase the ability of glucocor-
ticoids to activate in many different tissues both 
glucocorticoid receptors and mineralocorticoid 
receptors, resulting in increased transcription of 
both, with a consequent increase in blood pressure. This 
increase in glucocorticoid sensitivity may be exacerbated 
by overactivation of the hypothalamic-pituitary-adrenal 
axis, as several previous studies have shown that prenatal 
glucocorticoids elevate adult plasma corticosterone (55), 
apparently driven by increased expression of hypothalamic 
corticotrophin-releasing hormone (56). Consistent with the 
proposal that increased renal glucocorticoid sensitivity un-
derlies programmed hypertension, expression of the renal 
glucocorticoid-responsive genes, Na+/K+-ATPase-α1, or (as 
shown in the aforementioned and other studies) the Na+/
K+-ATPase-ß1 subunit, ACE and renin were all elevated 
in 16-week-old offspring of low-protein mothers. These 
programmed changes would be expected to increase renal 
sodium retention and thereby elevate plasma volume and, 
thus, blood pressure. A similar mechanism seems to underlie 
hypertension in a rat maternal low-protein programming 
model in which adult offspring have higher renal expres-
sion of Na+/K+-ATPase-ß1 and/or also -α1 (50); however, 
the Na+/K+-ATPase expression were not confirmed by the 
present data in 16-week-old offspring (20). 
It is not possible to rule out other mechanisms involved 
in the inappropriate retention of sodium. The maternal 
protein restriction model for IUGR in rats resulted in the up-
regulation of two critical Na+ transporters. The Na+/K+-2Cl 
and the Na-Cl co-transporters, but not the Na+/H+ nor the 
Na+ channel, were significantly increased in the rats with 
IUGR (48). These alterations led to a lower rate of urinary 
sodium excretion, associated with sodium retention and 
hypertension.
Apoptosis
Nephrogenesis is a complex process involving cell in-
tegration, cell growth and apoptosis. The rapid remodeling 
of structures requires massive apoptosis. Bcl-2 is an anti-
apoptosis protein that attenuates the effect of cytochrome 
c release from the mitochondria and counters the effects of 
the pro-apoptosis protein, Bax. Bcl-2 and Bax contribute to 
the signaling pathways that activate caspase-3, an enzyme 
that is necessary for the condensation of chromatin and 
fragmentation of DNA that characterize apoptosis (57). 
Bax and Bcl-2 are known to be expressed during normal 
kidney development, and their expression is known to be 
deregulated under certain conditions associated with per-
turbed nephrogenesis and apoptosis (58). 
Using real-time PCR in E13.0 metanephroi, Welham et 
al. (59) observed a step-wise increase in the expression of 
both Bax and Bcl-2 in the low-protein group. The increase 
was greater for the pro-apoptotic gene, Bax, versus the 
anti-apoptotic gene, Bcl-2, perhaps suggesting that a low-
protein diet shifts the balance of expression to up-regulate 
the death of metanephric precursor cells. In a prior study 
(58), the same group showed that low-protein diets reduce 
the final numbers of glomeruli, in association with the in-
creased deletion of precursors at the start of metanephric 
development, and present a significant increase in the 
numbers of apoptotic nuclei per unit area at E13, almost 
totally restricted to the renal mesenchyme.
In a model of uteroplacental insufficiency and the 
subsequent IUGR, a study observed increased renal p53 
hypomethylation in association with increased p53 and Bax 
mRNA protein, as well as decreased Bcl-2 mRNA, which 
leads to increased caspase-3 activity (57). Alterations in 
DNA methylation and histone acetylation in IUGR rats (60) 
suggest a molecular mechanism by which a low-protein 
diet and IUGR induce fetal renal apoptosis, with a result-
ing permanent loss of glomeruli. It would be interesting to 
better understand how the maternal environment alters the 
methylation status and the transcriptional rate of genes 
such as Bcl-2 and Bax.
Our group’s recent findings have shown that, in a small 
study, metanephroi extracted from undernourished rats 
and grown in culture for 48 h have fewer ureteric branches 
when compared with normal metanephric development in 
culture (Mesquita FF, Arena D, Ewen-McCullen L, Gontijo 
JA, Bertram J, Boer PA, Armitage J, unpublished data). 
Figure 4. Effect of maternal protein restriction on kidney gene expression 
at 12 days of age (A) and 16 weeks of age (B). The figure shows the re-
sults obtained in whole-tissue extracts that were immunoblotted for Na+/
K+-ATPase in the NP and LP kidneys. Columns and bars represent the 
mean ± SEM. NP = normal protein; LP = low protein. *P < 0.05, NP vs LP 
(Student t-test).
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Perspectives and Conclusion
There is an increasing amount of evidence from human 
studies and experimental animal models demonstrating 
that perturbations of the intrauterine environment are one 
of the main causes of the morphological and physiological 
changes that occur in different organs, following undernutri-
tion in utero. In this brief review, we have concentrated on 
one organ, the kidney, and shown that adult hypertension, 
programmed by maternal exposure to a low-protein diet, 
is linked to marked changes in the renal expression of the 
glucocorticoid receptor, 11ß-HSD2, and components of the 
RAS. The function of the kidney depends on the hormonal 
cascade, physiological mechanisms and morphological 
patterns that work in synchrony; as such, any alterations 
in this balance can cause the development of disease 
during adult life. We also show that renal development, 
particularly nephron number, can be influenced by a number 
of environmental factors, and especially by exposure to a 
low-protein diet during critical periods, which are surpris-
ingly early in fetal life. It is suggested, but remains to be 
proven, that whenever nephron number is suboptimal, there 
are maladaptive adjustments to gene expression and long-
term kidney function that may lead to the development of 
cardiovascular disease. It is unlikely that renal malfunction 
alone is responsible for the development of hypertension. 
We suggest that central (brain) regulation of blood pressure 
may also be altered. This is an important area for future 
investigation.
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